Cytosorbents Corporation Share Price
Stocks
CTSO
US23283X2062
Advanced Medical Equipment & Technology
|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.4320 USD | +8.05% |
|
-5.88% | -32.42% |
| 05-13 | Cytosorbents Corporation, Q1 2026 Earnings Call, May 13, 2026 | |
| 05-13 | Cytosorbents Corporation Reports Earnings Results for the First Quarter Ended March 31, 2026 | CI |
| Market Cap | 25.07M 21.63M 19.92M 18.7M 35.08M 2.37B 35.46M 235M 91.83M 1.16B 94.06M 92.07M 4.02B | P/E Ratio 2026 * |
-2.34x | P/E Ratio 2027 * | 14.4x |
|---|---|---|---|---|---|
| Enterprise Value | 25.07M 21.63M 19.92M 18.7M 35.08M 2.37B 35.46M 235M 91.83M 1.16B 94.06M 92.07M 4.02B | EV / Sales 2026 * |
0.66x | EV / Sales 2027 * | 0.53x |
| Free-Float |
85.15% | Yield 2026 * |
-
| Yield 2027 * | - |
Last Transcript: Cytosorbents Corporation
| 1 day | +8.05% | ||
| 1 week | -5.88% | ||
| Current month | -12.00% | ||
| 1 month | -20.27% | ||
| 3 months | -38.95% | ||
| 6 months | -36.81% | ||
| Current year | -32.42% |
| 1 week | 0.37 |  | 0.47 |
| 1 month | 0.37 | | 0.53 |
| Current year | 0.37 | | 0.84 |
| 1 year | 0.37 | | 1.39 |
| 3 years | 0.37 | | 4.29 |
| 5 years | 0.37 | | 9.8 |
| 10 years | 0.37 | | 14.95 |
| Manager | Title | Age | Since |
|---|---|---|---|
Phillip Chan
CEO | Chief Executive Officer | 55 | 23/07/2008 |
Vincent Capponi
PSD | President | 68 | 27/04/2020 |
Peter Mariani
DFI | Director of Finance/CFO | 62 | 13/08/2024 |
| Director | Title | Age | Since |
|---|---|---|---|
Edward Jones
BRD | Director/Board Member | 77 | 24/07/2011 |
Phillip Chan
BRD | Director/Board Member | 55 | 31/12/2008 |
Alan Sobel
BRD | Director/Board Member | 65 | 12/11/2014 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 11-17 | Free | Chief Executive Officer | 100,000 | 0.1593% | ||
| 07/08/25 | Free | Chief Executive Officer | 242,000 | 0.3865% | ||
| 07/08/25 | Other | Chairman | 44,000 | 0.0703% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +8.05% | -5.88% | -60.37% | -87.33% | 25.07M | |
| +1.03% | +0.19% | +17.62% | -8.92% | 174B | |
| +1.34% | -1.31% | -18.67% | +28.93% | 146B | |
| +0.56% | -1.74% | -9.75% | -24.05% | 127B | |
| -0.32% | -3.69% | -53.12% | -12.29% | 69.72B | |
| +1.37% | +0.37% | +14.81% | -4.69% | 49.01B | |
| +0.95% | +0.34% | -23.42% | -33.71% | 44.74B | |
| +0.58% | -3.58% | +11.54% | +9.37% | 36.67B | |
| +0.63% | -2.08% | +4.52% | +36.51% | 34.91B | |
| -0.64% | +0.14% | -10.37% | -17.53% | 29.65B | |
| Average | +1.20% | -2.95% | -12.72% | -11.37% | 71.22B | |
| Weighted average by Cap. | +0.47% | -1.87% | -6.52% | -2.68% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 38.26M 33.02M 30.4M 28.54M 53.54M 3.62B 54.12M 359M 140M 1.77B 144M 141M 6.13B | 47.12M 40.67M 37.44M 35.14M 65.94M 4.46B 66.65M 442M 173M 2.18B 177M 173M 7.55B |
| Net income | -11.74M -10.13M -9.33M -8.76M -16.43M -1.11B -16.61M -110M -43.01M -543M -44.06M -43.12M -1.88B | 2.37M 2.05M 1.89M 1.77M 3.32M 225M 3.36M 22.26M 8.69M 110M 8.9M 8.72M 380M |
| Net Debt | - | - |
| Date | Price | Change | Volume |
|---|---|---|---|
| 15/06/26 | 0.4320 $ | +8.05% | 228,350 |
| 12/06/26 | 0.3998 $ | +3.01% | 440,468 |
| 11/06/26 | 0.3881 $ | -5.57% | 441,186 |
| 10/06/26 | 0.4110 $ | -2.72% | 76,842 |
| 09/06/26 | 0.4225 $ | +2.00% | 94,802 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- CTSO Stock
Select your edition
All financial news and data tailored to specific country editions
